4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-025510
Director bought 500 shares at $10.11 ($5,053)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Katz Ilan Director | 2021-10-13 | Purchase | +500 | $10.11 | $5,053 | 1,500 | D: show line 1 in the form |
| Open-market purchases · 500 sh · avg $10.11 · $5,053 | |||||||
Loading xslF345X03/ownership.xml…